This protocol addresses tularemia in the neonatal age group: full-term infants aged ≤28 days, and premature infants who have reached 37–44 weeks postmenstrual age. Antimicrobial selection in this population is constrained by age-specific safety considerations.
When other recommended antimicrobial options have been exhausted, specific third-tier agents may be considered. The full selection criteria, agent choice, and clinical decision pathway are detailed in the complete protocol.
For these recommendations, neonates are defined as full-term infants aged ≤28 days or infants born premature who have reached 37–44 weeks postmenstrual age.
Chloramphenicol and streptomycin are third-tier options for treatment of tularemia in neonates and can be considered if other recommended antimicrobial options have been exhausted.
View source ↗